06Dec 2022
NAFLD, MAFLD and obesity: brothers in arms?

NAFLD, MAFLD and obesity: brothers in arms?

2022 was a proficuous year in both the nonalcoholic fatty liver disease (NAFLD) and obesity fields. Pharmacological treatment for obesity and NAFLD is moving forward, with the possibility of replacing bariatric surgery, artificial intelligence might help us access the histological effects of new drugs, and there were advances in personalized hepatocellular carcinoma screening in patients with NAFLD.

  • #gastroenterology

Like

Save

Share